Remdesivir’s EU Approval For COVID-19 Due Within Days

Gilead's Antiviral Drug Gets CHMP OK

Remdesivir antiviral injectable drug vaccine medicine vial Covid-19 Corona Virus 2019-ncov syringe injection. Vaccination, treatment to cure Covid 19 Corona Virus disease. No brand, own design concept
Remdesivir is seen as one of the most promising potential therapies for COVID-19 • Source: Shutterstock

Gilead Sciences’ Veklury (remdesivir) is expected to be approved in the EU for treating COVID-19 in a matter of days after the European Medicines Agency today decided that the product should be granted conditional marketing authorization (CMA).

The EMA’s decision to recommend approval for the investigational drug was made during the June meeting of the agency’s drug...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography